UB Paderborn / Katalog / Suche / in CDI

Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses

Acta dermato-venereologica, 2021-01, Vol.101 (1), p.adv00358-adv00358

2021

Volltextzugriff (PDF)

The Effect of Vortioxetine on Health-related Quality of Life in Patients With Major Depressive Disorder

Clinical therapeutics, 2015-10, Vol.37 (10), p.2309-2323.e6

2015

Volltextzugriff (PDF)

A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder

The international journal of neuropsychopharmacology, 2018-02, Vol.21 (2), p.97-107

2018

Volltextzugriff (PDF)

Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant

Expert review of pharmacoeconomics & outcomes research, 2021-01, Vol.21 (1), p.29-42

2021

Volltextzugriff (PDF)

Use of complete clearance for assessing treatment efficacy for 5-fluorouracil interventions in actinic keratoses: how baseline lesion count can impact this outcome

Journal of market access & health policy, 2020, Vol.8 (1), p.1829884-1829884

2020

Volltextzugriff (PDF)

Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies

Current medical research and opinion, 2014-12, Vol.30 (12), p.2589-2606

2014

Volltextzugriff (PDF)

Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland

Expert review of pharmacoeconomics & outcomes research, 2017-05, Vol.17 (3), p.293-302

2017

Volltextzugriff (PDF)

Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder

Current medical research and opinion, 2016-02, Vol.32 (2), p.351-366

2016

Volltextzugriff (PDF)

Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting

Clinical therapeutics, 2012-06, Vol.34 (6), p.1364-1378

2012

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Pharmaceutical Treatment Options in the First-Line Management of Major Depressive Disorder in Belgium

PharmacoEconomics, 2014-05, Vol.32 (5), p.479-493

2014

Volltextzugriff (PDF)

Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study

BMC psychiatry, 2018-03, Vol.18 (1), p.80-80, Article 80

2018

Volltextzugriff (PDF)

Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea

Expert review of pharmacoeconomics & outcomes research, 2016-09, Vol.16 (5), p.629-638

2016

Volltextzugriff (PDF)

From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses

Journal of market access & health policy, 2019, Vol.7 (1), p.1603538-1603538

2019

Volltextzugriff (PDF)

Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay study

Lung cancer (Amsterdam, Netherlands), 2011-04, Vol.72 (1), p.114-118

2011

Volltextzugriff (PDF)

Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder

European neuropsychopharmacology, 2017-08, Vol.27 (8), p.773-781

2017

Volltextzugriff (PDF)

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder

Brain and behavior, 2017-03, Vol.7 (3), p.e00622-n/a

2017

Volltextzugriff (PDF)

A multicenter prospective observational study of the conformity of temozolomide prescriptions in France

Pharmacoepidemiology and drug safety, 2012-08, Vol.21 (8), p.828-834

2012

Volltextzugriff (PDF)

Taking charge and caring for patients given antiretroviral prophylatics: evaluation of professional practice

Santé publique (Vandoeuvre-lès-Nancy, France), 2010-01, Vol.22 (4), p.393-403

2010

Volltextzugriff (PDF)

C8-05: Critical review of meta-analyses of randomized controlled trials (RCTs) studying lung cancer treatment: assessment of their quality

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S384-S384

2007

Volltextzugriff (PDF)

Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram

Journal of market access & health policy, 2015, Vol.3 (1), p.26776

2015

Volltextzugriff (PDF)

Prise en charge et suivi des patients traités par prophylaxie antirétrovirale : évaluation des pratiques professionnelles

Santé publique (Vandoeuvre-lès-Nancy, France), 2010, Vol.22 (4), p.393-403

2010

Volltextzugriff (PDF)

Management and follow-up of patients treated with antiretroviral prophylaxis: an evaluation of professional practices

Santé publique (Vandoeuvre-lès-Nancy, France), 2010-07, Vol.22 (4), p.393-403

2010

Volltextzugriff (PDF)

Prise en charge et suivi des patients traités par prophylaxie antirétrovirale : évaluation des pratiques personnelles

Santé publique (Vandoeuvre-lès-Nancy, France), 2010, p.393-403

2010

Volltextzugriff (PDF)

Linking biodiversity, ecosystem services, and beneficiaries of tropical dry forests of Latin America: Review and new perspectives

Ecosystem services, 2019-04, Vol.36, p.100909, Article 100909

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses

The Effect of Vortioxetine on Health-related Quality of Life in Patients With Major Depressive Disorder

A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder

Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant

Use of complete clearance for assessing treatment efficacy for 5-fluorouracil interventions in actinic keratoses: how baseline lesion count can impact this outcome

Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies

Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland

Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder

Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting

Cost-Effectiveness Analysis of Pharmaceutical Treatment Options in the First-Line Management of Major Depressive Disorder in Belgium

Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study

Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea

From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses

Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay study

Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder

A multicenter prospective observational study of the conformity of temozolomide prescriptions in France

Taking charge and caring for patients given antiretroviral prophylatics: evaluation of professional practice

C8-05: Critical review of meta-analyses of randomized controlled trials (RCTs) studying lung cancer treatment: assessment of their quality

Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram

Prise en charge et suivi des patients traités par prophylaxie antirétrovirale : évaluation des pratiques professionnelles

Management and follow-up of patients treated with antiretroviral prophylaxis: an evaluation of professional practices

Prise en charge et suivi des patients traités par prophylaxie antirétrovirale : évaluation des pratiques personnelles

Linking biodiversity, ecosystem services, and beneficiaries of tropical dry forests of Latin America: Review and new perspectives

Suchergebnisse filtern